{
    "2019-10-07": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Walmart, Travelers share losses lead Dow's nearly 50-point fall",
                "features": {
                    "keywords": [
                        "Walmart",
                        "Travelers",
                        "share losses",
                        "Dow",
                        "50-point fall"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "retail",
                        "insurance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-22",
                "original_text": "Theravance Pipeline Strong, Dependence on Yupelri a Concern",
                "features": {
                    "keywords": [
                        "Theravance",
                        "Pipeline",
                        "Strong",
                        "Dependence",
                        "Yupelri",
                        "Concern"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-10",
                "original_text": "The Zacks Analyst Blog Highlights: J&J, AstraZeneca, Roche, Glaxo and Merck",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "J&J",
                        "AstraZeneca",
                        "Roche",
                        "Glaxo",
                        "Merck"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-08",
                "original_text": "Johnson & Johnson Releases Inaugural You Belong: Diversity & Inclusion Impact Review",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Inaugural",
                        "You Belong",
                        "Diversity",
                        "Inclusion",
                        "Impact Review"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}